VIR insiders executed 10b5-1 sales totaling 524,297 shares in Oct 2025
Rhea-AI Filing Summary
SVF Endurance (Cayman) Ltd and affiliated reporting persons disclosed insider sales of 524,297 shares of Vir Biotechnology, Inc. (VIR) across two dates in early October 2025. The sales occurred on 10/03/2025 and 10/06/2025 at weighted average prices of approximately $5.5553 and $5.6878, respectively, and were executed under a Rule 10b5-1 trading plan established on 09/03/2025. Following these disposals the reporting group beneficially owned 16,159,744 shares.
The filing clarifies that SVF Endurance (Cayman) Limited is the record holder and is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P., with SB Investment Advisers (UK) Limited appointed as the alternative investment fund manager responsible for investment decisions.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-arranged trading and potential affirmative defense
- Full disclosure of weighted-average prices with an undertaking to provide per-transaction breakdowns on request
Negative
- Material reduction of position: 524,297 shares sold, which reduces liquidity cushion
- Share price pressure risk from additional plan-driven sales given prices in the low-$5 range
Insights
Insider sales followed a pre-established Rule 10b5-1 plan, reducing the group stake while preserving disclosure transparency.
The sales of 524,297 shares were executed under a documented 10b5-1 plan dated 09/03/2025, which provides an affirmative defense against claims of trading on nonpublic information when the plan meets regulatory conditions. That structure typically indicates pre-planned liquidity rather than opportunistic trading.
Key dependencies include continued compliance with plan terms and the manager's role: SB Investment Advisers (UK) Limited is identified as the AIFM and thus has exclusive decision authority for SVF's holdings; monitor any future Form 4 filings for changes to plan parameters or additional disposals in the coming months.
Market impact is likely modest given the trade size versus the fund's residual stake, but the weighted prices show recent trading near the low-$5 range.
The combined disposal of 524,297 shares at weighted averages of $5.5553 and $5.6878 signals executed liquidity at prices between $5.355 and $5.823. The reporting group still holds 16,159,744 shares, indicating the sales were a partial reduction rather than an exit.
Watch subsequent filings over the next 30-90 days for additional plan-driven sales or any amendments that could alter the rate of disposals; near-term share-price sensitivity may increase if further scheduled sell orders are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 73,955 | $5.6878 | $421K |
| Sale | Common Stock | 450,342 | $5.5553 | $2.50M |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.355 to $5.823. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.58 to $5.82. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
